A detailed history of Brinker Capital Investments, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 24,392 shares of WVE stock, worth $171,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,392
Previous 24,392 -0.0%
Holding current value
$171,719
Previous $158,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$5.48 - $8.1 $28,397 - $41,974
5,182 Added 26.98%
24,392 $158,000
Q1 2025

Jul 31, 2025

BUY
$8.08 - $13.51 $27,625 - $46,190
3,419 Added 21.65%
19,210 $155,000
Q4 2024

Jul 31, 2025

BUY
$8.0 - $16.44 $6,800 - $13,974
850 Added 5.69%
15,791 $195,000
Q3 2024

Jul 31, 2025

BUY
$5.12 - $9.01 $76,497 - $134,618
14,941 New
14,941 $122,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $611M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.